Biosimilar News: Selarsdi Scores FDA Approval for Interchangeability With Stelara
The U.S. FDA has approved Teva Pharmaceuticals and Alvotech’s Selarsdi injection, a biosimilar to Stelara (ustekinumab), as an interchangeable treatment for inflammatory conditions.